They need to raise the price of K by at least 100% by mid-yr to make K economically viable for them to self-finance an overseas launch and become profitable. You cannot threaten big pharma ("going it alone") if you don't have the means to execute it. If you cannot raise the price of K significantly or become profitable before the majority of cash is depleted, then take whatever big pharma is offering you, and call it a day. The longer they wait, the more new gout therapies will come to mkt. Dr Meeker and the bd need to negotiate a deal and end this nonsense asap.
Sentiment: Strong Buy